Organism: human
Organism: Plasmodium falciparum
Organism: Plasmodium knowlesi
OrganismPart: red blood cells
OrganismPart: erythrocytes
Disease: malaria
MaterialType: infected red blood cells
MaterialType: uninfected red blood cells
MaterialType: human blood
SampleTreatment: magnet purification
SampleTreatment: lysis in 8M urea in 50mM HEPES
SampleTreatment: sonication
SampleTreatment: reduction with 5mM DTT
SampleTreatment: alkylation with 14mM iodoacetamide
SampleTreatment: digestion with LysC
SampleTreatment: digestion with trypsin
SampleTreatment: acidification with trifluoroacetic acid
SampleTreatment: desalting on Sep-Pak lite C18 cartridges
SampleTreatment: TMT labelling
SampleTreatment: SCX fractionation
SampleTreatment: phosphopeptide enrichment with TiO2 beads
SampleTreatment: phosphopeptide enrichment with Fe-NTA kit
AlkylationReagent: iodoacetamide
ReductionReagent: DTT
CleavageAgent: LysC
CleavageAgent: trypsin
Label: TMT
Label: carbamidomethyl (C)
Modification: oxidation (M)
Modification: deamidation (NQ)
Modification: phosphorylation (S, T, Y)
EnrichmentMethod: TiO2 enrichment
EnrichmentMethod: Fe-NTA enrichment
FractionationMethod: SCX chromatography
Separation: reverse phase chromatography
Instrument: Orbitrap Lumos
Instrument: Q-Exactive mass spectrometer
AcquisitionMethod: data-dependent acquisition
FragmentationMethod: HCD
MS2MassAnalyzer: Orbitrap
PrecursorMassTolerance: 20 ppm (first search)
PrecursorMassTolerance: 4.5 ppm (main search)
FragmentMassTolerance: 0.003 Da (reporter mass tolerance)
FactorValue: infection status (P. falciparum, P. knowlesi, uninfected)
FactorValue: genetic knockout (DMSO vs RAP-treated FIKK KO lines)
NumberOfSamples: 10 samples
Temperature: 37degreesC